Šibenik connects its fortresses by minibus

first_imgAs part of the European project “Revitalization of the fortress of St. Ivan ”, the City of Šibenik procured a midibus with the aim of conducting educational programs and workshops, ie, for the needs of transfers and tours of archaeological sites in the Šibenik-Knin County, as part of the field work of the educational campus of St. Ivan. Also, all three Šibenik fortresses will be connected by bus.”We will connect all three fortresses by bus, and will serve in carrying out various educational activities intended primarily for children, the domicile population, but also tourists. Our goal is to extend the season, and just one of the facilities at the Fortress of St. Ivana is an educational campus intended for educational programs that will last all year round. Fortress of St. Ivana will be the starting point, and all cultural and archaeological assets in the city of Šibenik and its surroundings will be the subject of visits and various activities.Said the mayor of Sibenik, Zeljko Buric.Midibus, Otokar Navigo C brand, has a total capacity of 40 people, including wheelchairs. The total financial value of the project “Revitalization of the Fortress of St. Ivana ”amounts to HRK 50.014.742,95. The European Union co-finances the project with HRK 41.486.646,05 from the European Structural and Investment Funds within the Operational Program Competitiveness and Cohesion, while the rest of the funds are provided by the City of Šibenik.last_img read more

National consortium aims to finish local COVID-19 vaccine in 18 months

first_imgPrevious research identified at least three different types of coronavirus strains affecting the world – types G, S and V. Ali said that many samples sent from Indonesia apparently did not match the aforementioned three types, meaning that scientists had to develop local vaccines to combat the coronavirus strain in the country.The whole genome sequencing is part of the initial stage of vaccine development, as it will allow scientists to determine the complete RNA sequence of specific coronavirus strains. Subsequently, scientists will be able to detect the antigen of the virus strain in Indonesia.Apart from doing the sequencing, Indonesia is also collaborating with several countries, including South Korea, to develop a vaccine.Local pharmaceutical company PT Kalbe Farma, for example, is working with a South Korean company for the development of a vaccine using a DNA virus platform. “Phase two of the project’s clinical trial is scheduled for August 2020,” Ali said.Topics : Indonesia’s national consortium for COVID-19 vaccine development is aiming to finish its work within the next 18 months in an effort to eradicate the coronavirus in the country.”Vaccines usually take years to develop. However, given the emergency situation, we are currently expected to develop local vaccines in around 18 months,” consortium chairman Ali Ghufron Mukti said during a press conference on Thursday.He said the country had submitted 16 complete genome sequences of Indonesian strains to GISAID, an initiative that promotes the sharing of genetic data on influenza viruses and the coronavirus. Three of them have so far been classified as “unidentified strains”, while one was identified as “type G”.last_img read more